The European Investment Bank (EIB) has provided €24m in funding to Austria’s F2G Biotech to support the latter’s research and anti-fungal drug development.
The European Investment Bank (EIB) has provided €24m in funding to Austria’s F2G Biotech to support the latter’s research and anti-fungal drug development.
The European Investment Bank (EIB) has provided €24m in funding to Austria’s F2G Biotech to support the latter’s research and anti-fungal drug development.